Choosing not to use genetic testing is an option. Ignorance isn’t.
Daniel McArthur and Daniel Vorhaus have a beef: Earlier this month, the Sunday Times published an op-ed piece by Camilla Long critiquing the practice and business of direct-to-consumer (DTC) genetic...
View ArticleYour genetic info — not free, easy, or clear
After I wrote in my Atlantic article about getting my serotonin transporter gene assayed (which revealed that I carry that gene’s apparently more plastic short-short form), I started getting a lot of...
View ArticleDoes Your Genetic Information Long to Be Free? You’re fixin’ to find out
John Hawks ponders the day, very soon to come, when high school students will run their genome sequences in bio lab instead of their blood types. He’s riffing off an article by Ronald Bailey in Reason...
View ArticleEmbrace Your Dangerous Genome
Virginia Hughes is “sick of reading about the dangers of the genome.” So she complains over at Slate, eloquently, and I’m sick right with her. Hughes, who blogs at National Geographic and is among our...
View ArticleThe Case for Selective Paternalism in Genetic Testing
Image: Gravitywave/Flickr Last week, in Embrace Your Dangerous Genome, I argued (following Virginia Hughes’ Slate article) that we should press for more openness and less worry about people receiving...
View ArticleWhat Does the FDA Want From 23andMe?
Here’s a particularly sharp, context-rich post on that question from from Margaret Curnutte, currently of Baylor University. It seems one of the more deeply informed takes on this fracas. A couple of...
View ArticleI Got Your 23andMe – FDA Food Fight Links Right Here
Who’s over the line here? Below find my ever-growing annotated collection of online responses to the FDA’s recent shot across the bow of 23andMe, the consumer genetics company. Until today, I was...
View ArticleIs The National Cancer Institute Telling Me to Remove My Breasts?
One of the key issues in the dust-up over the FDA’s insistence on regulating 23andMe’s service is the question of how 23andMe’s health-risk results differ from other forms of health-risk information....
View Article23andMe Ceases Providing Health-Risk Info; Ancestry Only Now
The company announced today that in reaction to the FDA’s order to marketing health-related information based on its genetic testing, it will cease providing that information to anyone who signed on...
View ArticleWill the FDA Regulate Just Genetic Risk Data, or All Risk Data?
That might not be good for your heart, if you don’t mind me saying so. The latest in the 23andme versus FDA saga, in which the FDA halted 23andme from offering health-risk analyses of the genotyping...
View Article
More Pages to Explore .....